Loading...
PRHI is not a good buy right now. With no proprietary buy signals, weak near-term pattern odds (next week skew negative), and a sharp YoY revenue collapse with widening losses in 2025/Q3, the risk/reward is unfavorable for an impatient buyer looking for immediate upside.
Price/Trend: PRHI is trading around 0.695 (+0.70% regular session) but was -2.13% pre-market, suggesting fragile demand. Momentum: MACD histogram is positive (0.0161) and expanding, which is a mild bullish momentum tailwind. RSI: RSI(6) at ~53 is neutral—no oversold bounce setup. Moving Averages: Converging MAs indicate a non-committal/indecisive trend rather than a clean uptrend. Levels: Pivot 0.676 is the key near-term line. Resistance at 0.805 then 0.884; support at 0.547 then 0.468. Upside requires clearing 0.805; failure to hold ~0.676 raises risk of a push toward 0.547. Pattern-based outlook: Similar-pattern stats imply ~+0.89% next day, but -2.55% next week and -0.96% next month—tilting against a buy now for quick gains.
Intellectia Proprietary Trading Signals
which can act as a near-term launch point if buyers step in.
Financial deterioration in the latest quarter (2025/Q3): large YoY revenue drop and deeper losses.
No recent news/catalysts to drive a sustained re-rating.
No notable hedge fund or insider accumulation trends reported (both neutral).
Pattern-based probabilities skew negative over the next week/month.
Pre-market weakness (-2.13%) despite a modest regular-session gain points to limited conviction.
Latest quarter: 2025/Q3. Revenue: 6.679M, down -58.30% YoY (sharp contraction). Net Income: -3.970M, down -107.52% YoY (losses deepened materially). EPS: -0.32, down -107.41% YoY. Overall: The quarter shows negative growth trends (shrinking revenue with worsening profitability), which does not support a near-term bullish entry without a clear catalyst.
No analyst rating or price target change data was provided, so there is no observable recent Wall Street trend to lean on. Based on available fundamentals, the main 'pro' case would be technical stabilization/bounce potential; the 'con' case is the steep revenue decline and worsening losses, which outweighs the technical tailwind for a buy-now decision. Politician/congress activity: No recent congress trading data available.
